Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events

I. Avivi, N. Lanir, R. Hoffman, Benjamin Brenner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Homocysteine plasma levels were measured by high-performance liquid chromatography in 52 patients with primary anti-phospholipid syndrome (APS). Elevated homocysteine concentrations (≥ 15 μmol/l) were found in 16/52 (30.8%) APS patients. Elevated homocysteine levels were found to be associated with an increased risk for a major thromboembolic event (50 versus 16.7%, P = 0.014). Hyperhomocysteinemia is a common finding in APS patients, and may contribute to severity of thrombotic tendency observed in this syndrome.

Original languageEnglish
Pages (from-to)169-172
Number of pages4
JournalBlood Coagulation and Fibrinolysis
Volume13
Issue number2
DOIs
StatePublished - Mar 2002
Externally publishedYes

Keywords

  • Antiphospholipid syndrome
  • Hyperhomocysteinemia
  • Thromboembolism

Fingerprint

Dive into the research topics of 'Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events'. Together they form a unique fingerprint.

Cite this